Invasive brain‑computer interfaces represent the most promising technical pathway for high‑fidelity neuronal signal acquisition and the restoration of impaired neural functions.
Indian surgical‑robotics enterprise SS Innovations delivered an impressive growth performance in the first half of 2026.
DARPA is concurrently advancing two cutting‑edge technology pathways related to the brain.
Recently, the U.S. has launched a landmark collective research program on autonomous surgical robots.
On July 28, Zhongke Xianjian co-hosted an IIT clinical investigator meeting on implantable cortical vision restoration brain-computer interfaces together with Shenzhen Eye Hospital, The Second People’s Hospital of Shenzhen, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, and
In January 2026, uSurg DoctorX, the thoracoabdominal endoscopic surgical system under United Imaging Healthcare, secured its first registration approval from the National Medical Products Administration (NMPA), obtaining official regulatory qualification for commercial launch.
Over the past two decades, the core thread of human-machine interaction has been enabling machines to better interpret human "commands".
On July 23, 2026, Momentis Surgical, an Israeli surgical robotics company, officially announced that the multi-port configuration of its Anovo® surgical system has secured U.S. FDA 510(k) clearance.
In July 2026, the National Health Commission of the People’s Republic of China and two other relevant central departments jointly issued the Circular on Further Improving the Centralized Procurement of Medical Equipment in Public Medical and Health Institutions, which explicitly brought laparoscopic
On July 16, GE Healthcare announced a 10-year strategic partnership worth $500 million (approximately 3.4 billion Chinese yuan) with Catholic Health.
Long‑dominated by overseas brands that left China with no alternative, the surgical‑robot sector now sees Chinese‑made equipment powering one out of every two robotic‑assisted remote surgeries worldwide. Through over a decade‑long journey of continuous innovation, China’s surgical‑robot industry has
On July 9, 2026, the Financial Times of the UK cited people familiar with the matter as reporting that Blackstone and TPG are looking to sell Hologic’s Surgical Unit for more than $4 billion (approximately 27.2‑billion Chinese yuan) and have engaged advisors to push forward with the deal.
Recently, Nature published a groundbreaking medical study, in which an engineering and surgical team from the University of California, San Diego (UCSD) accomplished the world‑first‑ever in‑vivo surgical trial performed by a remotely operated humanoid robot.
On July 8, Johnson & Johnson officially announced that its Dual‑Energy THERMOCOOL SMARTTOUCH‑SF (DE‑ST‑SF) dual‑energy ablation platform has secured US FDA clearance for market launch. It marks the world’s first interventional device enabling seamless switching between radio‑frequency ablation (RF)
On July 7, 2026, Japanese surgical robotics company Medicaroid officially announced that its self-developed Hinotori laparoscopic surgical robot has successfully obtained the EU CE-MDR certification.
In the first half of 2026, the commercialization of domestic surgical robots is entering a critical stage of accelerated rollout.
According to an announcement from Jiejing Medical, the company’s single-use electronic upper and lower gastrointestinal imaging catheters have successfully passed review by the Liaoning Provincial Drug Administration and officially obtained Class II Medical Device Registration Certificates.
Both organisations plan to use Olympus' network and EndoRobotics' expertise to make the solutions globally available.
New data on the pulsed-field ablation (PFA) device class debuts at HRS 2026 as the field catches the eye of several large medtech companies.
UT Austin researchers developed a dual-light 3D printing method using resin that creates objects with both soft and hard properties, promising advances in prosthetics and medical devices that better interface with the human body.